Approval · Notice of Compliance 1454 · 2003
VISIPAQUE: Notice of Compliance 1454
Issued April 23, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1454
- Date
- April 23, 2003
- Company
- Amersham Health Inc.Mississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Non-ionic radiographic contrast medium